Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Infection, Genetics and Evolution

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.meegid.2011.11.006PMID 22119749PMCID PMC3293939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.

  2011cited by this paper
• HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment.

  2011cited by this paper
• Identification of Drug Therapy Problems in Patients with Diabetes Treated in a Secondary Care Facility in Benin City

  2011cited by this paper
• Environmental, pharmacological and genetic influences on the spread of drug-resistant malaria

  2011cited by this paper
• How can we identify parasite genes that underlie antimalarial drug resistance?

  2011cited by this paper
• How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance.

  2011cited by this paper
• Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing

  2010cited by this paper
• Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria.

  2010cited by this paper
• Decreasing Burden of Malaria in Pregnancy in Malawian Women and Its Relationship to Use of Intermittent Preventive Therapy or Bed Nets

  2010cited by this paper
• Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations

  2010influential reference
• Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia.

  2010cited by this paper
• The Selection Landscape of Malaria Parasites

  2010cited by this paper
• Quantifying the evolution and impact of antimalarial drug resistance: drug use, spread of resistance, and drug failure over a 12-year period in Papua New Guinea.

  2010cited by this paper
• Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.

  2010cited by this paper
• Compensatory mutations restore fitness during the evolution of dihydrofolate reductase.

  2010cited by this paper
• Detecting signatures of balancing selection to identify targets of anti-parasite immunity.

  2010cited by this paper
• High Resistance of Plasmodium falciparum to Sulphadoxine/Pyrimethamine in Northern Tanzania and the Emergence of dhps Resistance Mutation at Codon 581

  2009cited by this paper
• Multiple Origins and Regional Dispersal of Resistant dhps in African Plasmodium falciparum Malaria

  2009cited by this paper
• A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria

  2009cited by this paper
• Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment

  2009cited by this paper
• Stepwise acquisition of pyrimethamine resistance in the malaria parasite

  2009cited by this paper
• MalHaploFreq: A computer programme for estimating malaria haplotype frequencies from blood samples

  2008cited by this paper
• Detection of the dihydrofolate reductase-164L mutation in Plasmodium falciparum infections from Malawi by heteroduplex tracking assay.

  2008cited by this paper
• Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana.

  2008cited by this paper
• A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa.

  2007cited by this paper
• Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.

  2007cited by this paper
• Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.

  2007cited by this paper
• Intensity of malaria transmission and the spread of Plasmodium falciparum resistant malaria: a review of epidemiologic field evidence.

  2007cited by this paper
• Potential Impact of Intermittent Preventive Treatment (IPT) on Spread of Drug-Resistant Malaria

  2006cited by this paper
• WITHIN‐HOST COMPETITION IN GENETICALLY DIVERSE MALARIA INFECTIONS: PARASITE VIRULENCE AND COMPETITIVE SUCCESS

  2006cited by this paper
• Drug resistance models for malaria.

  2005cited by this paper
• Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.

  2005cited by this paper
• Mutations Associated with Sulfadoxine-Pyrimethamine and Chlorproguanil Resistance in Plasmodium falciparum Isolates from Blantyre, Malawi

  2005cited by this paper
• Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?

  2005cited by this paper
• Intensity of malaria transmission and the evolution of drug resistance.

  2005cited by this paper
• The origins and spread of antimalarial drug resistance: lessons for policy makers.

  2005cited by this paper
• Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study

  2004cited by this paper
• Intercontinental Spread of Pyrimethamine-Resistant Malaria

  2004cited by this paper
• Effectiveness of intermittent preventive treatment with sulphadoxine‐pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital‐based study

  2004cited by this paper
• Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan.

  2004cited by this paper
• High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.

  2003cited by this paper
• Malaria control and the evolution of drug resistance: an intriguing link.

  2003cited by this paper
• The puzzling links between malaria transmission and drug resistance.

  2003cited by this paper
• Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria.

  2003cited by this paper
• Molecular Determination of Point Mutation Haplotypes in the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum in Three Districts of Northern Tanzania

  2003cited by this paper
• Plasmodium falciparum: PCR detection and genotyping of isolates from peripheral, placental, and cord blood of pregnant Malawian women and their infants.

  2002cited by this paper
• The evolution of drug-resistant malaria: the role of drug elimination half-life.

  2002cited by this paper
• Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.

  2002cited by this paper
• The burden of malaria in pregnancy in malaria-endemic areas.

  2001cited by this paper
• Antimalarial Drugs Clear Resistant Parasites from Partially Immune Hosts

  2001cited by this paper
• Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99.

  2000cited by this paper
• Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand.

  1999cited by this paper
• Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.

  1997cited by this paper
• Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.

  1997cited by this paper
• Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine.

  1994cited by this paper

• Interactions between antenatal sulfadoxine-pyrimethamine, drug-resistant Plasmodium falciparum parasites and delivery outcomes in Malawi.

  2020cites this paper
• Placentary Malaria, What Biological Diagnosis?

  2020cites this paper
• Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by Next Generation Sequencing of Plasmodium falciparum

  2019cites this paper
• Changing the policy for intermittent preventive treatment with sulfadoxine–pyrimethamine during pregnancy in Malawi

  2017cites this paper
• The genetic consequences of selection in natural populations

  2016cites this paper
• Molecular Epidemiology of Malaria in Pregnancy

  2016cites this paper
• Plasmodium falciparum dihydropteroate synthetase-A 581 G mutation reduces effectiveness of sulfadoxine-pyrimethamine preventive therapy in Malawian pregnant women

  2015cites this paper
• Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia

  2015cites this paper
• The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women.

  2015cites this paper
• In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi

  2015cites this paper
• Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study

  2014influential citation
• Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia

  2014cites this paper
• Mefloquine safety and tolerability in pregnancy: a systematic literature review

  2014cites this paper
• Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment

  2014cites this paper
• Independent Lineages of Highly Sulfadoxine-Resistant Plasmodium falciparum Haplotypes, Eastern Africa

  2014cites this paper
• Independent Lineages of Highly Sulfadoxine-Resistant Plasmodium falciparum Haplotypes,

  2014cites this paper
• Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria

  2013cites this paper
• Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and

  2013cites this paper
• The effect of antenatal monthly sulphadoxine–pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial

  2013cites this paper
• Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context.

  2013cites this paper
• The Characteristic Trajectory of a Fixing Allele: A Consequence of Fictitious Selection That Arises from Conditioning

  2013cites this paper
• Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11.

  2013cites this paper
• Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.

  2013cites this paper
• Changes in Malaria Parasite Drug Resistance in an Endemic Population Over a 25-Year Period With Resulting Genomic Evidence of Selection

  2013cites this paper
• The Effect of Monthly Sulfadoxine-Pyrimethamine, Alone or with Azithromycin, on PCR-Diagnosed Malaria at Delivery: A Randomized Controlled Trial

  2012influential citation
• Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.

  2012influential citation
• Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: the times they are a-changin'.

  2012cites this paper
• Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin Independent Lineages of Highly Sulfadoxine-resistant Plasmodium Falciparum Haplotypes, Eastern Africa

  year unknowncites this paper